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Abstract 
 
Background: Prevalence of breast cancer in Asian developing countries is much lower than western developed 
countries. The main aim of this study was to measure breast cancer prevalence in a defined population of Iran. 
 
Methods: A total of 25201 women who were under coverage of “Imam Khomeini Relief Foundation (IKRF)”, which 
is an organization for delivering supportive social and cultural services to the deprived and poor subgroups of the 
society, were involved in the study. The study was conducted during years 2007 and 2008. All subjects were inter-
viewed for their socio-demographic features and underwent precise clinical and para-clinical breast examination.  
 
Results: Mean age was 47 years with standard deviation 10 ranging from 11 to 88 years. Subjects were from 
deprived subgroups of the community; were mainly illiterate or had primary school education (86%) and majority 
of them (93%) had their first full-term pregnancy at age less than 26 years and also were multiparous. With con-
firmed diagnosis by breast biopsy, breast cancer prevalence was 0.15% (95%CI; 0.10-0.20).  
 
Conclusion: Compared with developed countries, Asian developing countries have been at a lower risk of 
breast cancer development. It is seen that more deprived subgroups are at much lower risk. The more industrial-
ized life is accompanied with more hazards. 
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Introduction 
 
Breast cancer is the most frequently diagnosed malig-
nancy among women in developed countries,
1-3 and in 
some developing countries.
4-6 Breast cancer is more 
prevalent in developed western countries than in devel-
oping Asian countries. Investigations have revealed that 
almost one in nine American women will suffer from 
breast cancer in their lifetimes
7,8 while the Western Eu-
ropean and North American population have the highest 
lifetime risk. Prevalence of breast cancer in these coun-
tries is estimated between 8 and 10%. However, the 
lowest prevalence is seen in Asian countries, about 1%.
9 
In Iran, the prevalence of breast cancer was reported to 
be 6.7 per thousand in 2002, which is less than the esti-
mates for Asian countries.
10 Several reports from Iran 
have reported that the prevalence of breast cancer in Iran 
is lower than in European and American countries but 
they did not report an exact measure.
11,12   
Breast cancer usually occurs at the time when 
women have important family and occupational roles, 
and thus any treatment in relation to this cancer would 
be particularly stressful for the patient and her family. 
Disparities in the prevalence of breast cancer have long 
been debated. As mentioned before the prevalence of 
breast cancer is low in Iran. The main aim of this study 
was to measure the prevalence of breast cancer in a 
specific group of women from low social class and 
deprived subgroups of Iranian population.  
 
 
Materials and Methods 
 
A total of 25201 women who were insured by the 
“Imam Khomeini Relief Foundation (IKRF)” were 
involved in this study. The “Imam Khomeini Relief 
Foundation (IKRF)” was established in 1980 in Is-
lamic Republic of Iran for delivering supportive   
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social and cultural services to deprived and poor sub-
groups of the society. Thus women in this study were 
mainly Vulnerable Household Women’s Health As-
sessment (VH-WHAT) from poor and low social 
subgroups1.
13 This study was conducted during a two 
years period from 2007 to 2009.  
Islamic Republic of Iran, in the Middle East region 
with an over 70 million population, consists of 30 
provinces with Tehran as its capital with more than 
10 million residents. Along with Tehran, 10 more 
province capitals including: Shiraz, Mashhad, Ker-
man, Kermanshah, Bushehr, Qom, Isfahan, Gorgan, 
Rasht and Yazd were included in this study. 
The statistics and number of vulnerable women 
was obtained from the provincial public service or-
ganizations (IKRF). Population size of each province 
capital was determined according to its population 
and allocated budget. 
All of the subjects were first interviewed for so-
cio-demographic data, drug history and history of 
cancer. Selected gynecologists and surgeons attended 
educational workshops to be oriented regarding the 
principals of a concise breast examination. Then in 
the appointment day, a gynecologist or surgeon per-
formed a complete breast examination to detect any 
lump or mass along with axillary lymph node exam. 
All participants in the range of 35 to 60 years then 
referred to designated radiology centers for mammog-
raphy. For those women above 60 or below 35 years 
of age, mammography was done according to physi-
cian’s opinion and results of breast examination.  
In some cases with suspicious results of mammog-
raphy, a breast ultrasonography was performed to 
evaluate any abnormal mass or lumps; in presence of 
any cystic lesion it was aspirated by needle.  All sus-
picious breast masses underwent biopsy for detection 
of malignant lesions and the breast cancer diagnosis 
was confirmed by the result of biopsy. All analysis 
was conducted using Stata v10. 
 
 
Results 
 
Mean age of the population study was 47 years with 
standard deviation of 10 years, ranging from 11 to 88 
years.  Only 2% were single while 19% were married 
and 79% were divorced or widowed women. Fifty 
eight percent reported their menarche at age 13 years 
or less and the rest at 14 years and above. Age of 
marriage in 70% of them was 18 years or less and in 
26% was 19 to 25 years and only 4% had age of mar-
riage at age 26 years or above. Fifty five percent had 
their first pregnancy at age 18 or less and 37% be-
tween age 19 to 25 and only 8% at age 26 years and 
above. Eighty eight percent were unemployed and 
received their life expenses from IKRF. Forty percent 
were illiterate and 47% had only primary school edu-
cation and only 3% had university education. Forty 
six percent had never used OCP, 47% had started to 
use OCP between ages 20 to 30 years and 7% at age 
above 30 years. However, duration of OCP use was 
not clear for the two last groups (Table 1). 
Number of pregnancies was significantly associat-
ed with diagnosis of breast cancer and those with a 
higher number of pregnancies were less likely to be 
diagnosed with breast cancer. Marital status, menar-
che age, age of marriage, age at first pregnancy, oc-
cupation and education were not associated with the 
disease diagnosis.  
About 1% of subjects had history of radiation ex-
posure and 6% had reported hormone therapy before 
the time study and these two factors were not associ-
ated with the disease diagnosis. Positive family histo-
ry of both breast cancer and ovarian cancer was about 
3%. Also family history of breast and ovarian cancer 
were significantly related and those with family histo-
ry of one cancer were more likely to have family his-
tory of another. Eighteen percent of breast cancer pa-
tients had reported family history of all other cancers. 
Only one of the breast cancer patients had been pre-
viously diagnosed with ovarian cancer. History of 
cancer in subjects and their families was not associat-
ed with the disease diagnosis.  
All of the subjects were examined for benign chang-
es in breast skin and nipple like redness and exfoliation. 
However, none of diagnosed patients with breast cancer 
had these changes in their breasts. Final diagnosis of 
breast cancer was confirmed in 38 of 25201 subjects of 
study which was 0.15%, 95%CI; 0.10-0.20. 
 
 
Discussion 
 
The results of this study showed that prevalence of 
breast cancer in the specific population of study was 
0.15% which is much lower than other studies on 
breast cancer prevalence from Iran.
10,11 The majorities 
of subjects in this study (93%) had their first full-term 
pregnancy at age less than 26 years and also were 
multiparous. Furthermore, those with a higher number 
of pregnancies were less likely to be diagnosed with 
breast cancer. It has been shown that early pregnancy Prevalence of breast cancer 
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and multiparity are protective factors for breast can-
cer development.
13 About half of subjects of this 
study had never used OCP and the rest had reported 
OCP use between ages 20 to 30 years without men-
tioning the duration of usage. In addition, apart from 
use of OCP, 94% of subjects had reported no hor-
mone replacement therapy. It has been also reported 
that prolonged exposure to exogenous estrogens and 
progestins in hormone therapy increased a woman's 
risk of developing breast cancer.
14 
Eighty six percent of our study population were il-
literate or had education level less than 6 years. A 
36% lower risk was observed for women with more 
than 16 years of education as compared to those with 
the lowest educational achievement (7-9 years).
15 Al-
cohol intake was another risk factor for breast cancer 
and none of subjects of this study were alcoholic.
15  
These characteristics of our study population 
could be a reason for the very low prevalence of 
breast cancer among them. Moreover, all subjects 
were from a low social class and deprived subgroups 
of Iran's population. Although recent studies have 
shown that breast cancer risk is increasing in devel-
oped countries, some studies reported that changes in 
risk of breast cancer differs in various ethnicities.
15,16 
The prevalence of breast cancer is much higher in 
developed countries but with a better prognosis. In 
Iran with a lower prevalence, it has been shown that 
the overall prognosis is worse when compared to de-
veloped countries.
17,18 
Furthermore, despite the high prevalence, the 
prognosis of breast cancer is better in the developed 
countries. However, although the prevalence of breast 
cancer in Iran is lower than that in the developed 
countries, the overall prognosis is worse.
19 Since this 
study was conducted on a specific group of Iran's 
population, further investigations on general popula-
tion are needed to measure the prevalence of breast 
cancer in normal population.  
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Table 1: Distribution of socio-demographic and reproductive features 
Variable   Percent  Variable Percent 
Marital status  
    Single 
    Married 
    Divorced 
    Widowed  
 
2 
19 
29 
50 
Education 
    Illiterate 
    Primary school 
    High school 
    University 
 
39 
47 
11 
3 
 Occupation 
    Manual 
    Non-manual 
    Housewife 
 
6 
5 
89 
Menarche age 
    ≤13 years 
    ≥14 years  
 
58 
42 
 Age at marriage 
    ≤18 years 
    19-25 years 
    ≥ 26 years  
 
70 
26 
4 
Age at first pregnancy 
    ≤18 years 
    19-25 years 
    ≥ 26 years 
 
55 
38 
7 
No. of pregnancies 
    0 
    1-5 
    6-10 
    ≥11 
 
5 
64 
27 
4 
OCP use 
    Never  
    Between age 20-30 
    Above age 30  
 
46 
47 
7 
Age at time of study 
    ≤25 years 
    26-39 years 
    40-49 years 
    50-64 years 
    ≥65 years   
 
1 
23 
37 
36 
3 
Smoking 
    Smoker 
    Ex-smoker 
    Never smoker 
 
3 
2 
95 
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